Is First Wave Biopharma, Inc. technically bullish or bearish?

Sep 20 2025 07:56 PM IST
share
Share Via
As of September 11, 2025, First Wave Biopharma, Inc. shows a bullish trend supported by strong technical indicators, despite some caution from the monthly RSI, with a remarkable 1-year return of 350.98% compared to the S&P 500's 17.14%.
As of 11 September 2025, the technical trend for First Wave Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, particularly in the weekly MACD, Bollinger Bands, KST, and OBV, all of which are bullish. The daily moving averages also confirm a bullish trend. However, the monthly RSI indicates bearishness, which suggests some caution.

In terms of performance, the stock has shown impressive returns, with a 1-year return of 350.98% compared to the S&P 500's 17.14%, and a year-to-date return of 146.52% against the S&P 500's 12.22%. Overall, the technical indicators point to a bullish outlook, albeit with some mixed signals in the monthly timeframe.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
First Wave Biopharma Hits New 52-Week High at $5.20
Sep 18 2025 01:22 PM IST
share
Share Via
First Wave Biopharma Hits New 52-Week High of $4.61
Sep 17 2025 03:20 PM IST
share
Share Via
First Wave Biopharma Hits New 52-Week High of $3.67
Sep 16 2025 11:30 AM IST
share
Share Via
Is First Wave Biopharma, Inc. overvalued or undervalued?
Jun 25 2025 09:08 AM IST
share
Share Via
What does First Wave Biopharma, Inc. do?
Jun 22 2025 06:51 PM IST
share
Share Via